NYHA Class IV Approval: In August 2024, scPharmaceuticals announced that the U.S. Food and Drug Administration (FDA) granted approval for FUROSCIX, expanding the indication to include New York Heart ...

The explosion of sophisticated technologies has created a greater urgency for centralization and an uptick in process ...

Digital Money Transfer and Remittances Market size is expected to reach USD 125 billion by 2033, projected at a CAGR of 18.2% ...

Recent Highlights and Anticipated Milestones Third Quarter 2024 Financial Results Cash Position ... public relations, and accounting services. Operating Loss: Operating loss was approximately $5.4 ...

A corporate is also a "large organisation ... misleading consumers or investors (including via non-financial information disclosures such as environmental and sustainability reporting), false ...

Finance leaders who can effectively harness the power of data are better positioned to meet today’s challenges and drive ...

A Management Report reviewing the Company’s third quarter 2024 financial results will be furnished to the Securities and Exchange Commission on Form 8-K and published on the Company’s website at https ...

Dr. Hennes' research interests revolve around financial reporting choices and disclosure. Her work has been published in The Accounting Review, Journal of Accounting and Public Policy, Accounting ...

Australia's corporate watchdog ... Julia Szlakowski says years before the AMP scandal broke at the financial services firm, she was fired from another job for not sleeping with her boss.

Grant amounts will be contingent on the cost of the applicant’s research project and the financial needs of the applicant. The inaugural Barry C. Melancon Professional Accounting Research ...

Picture your last corporate training session. Was it memorable? Did it change how you work? Probably not. But that's about to change. The convergence of artificial intelligence, immersive ...